These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 21437890)
21. Expression of p63 in thymomas and normal thymus. Dotto J; Pelosi G; Rosai J Am J Clin Pathol; 2007 Mar; 127(3):415-20. PubMed ID: 17276940 [TBL] [Abstract][Full Text] [Related]
22. [Clinicopathologic analysis of 52 cases of thymic epithelial tumor]. Ma YQ; Miao N; Abulajiang G; Li QX; Liu X; Zhang W; Wang CF; Wang J Zhonghua Bing Li Xue Za Zhi; 2010 Apr; 39(4):249-54. PubMed ID: 20654124 [TBL] [Abstract][Full Text] [Related]
23. The correlation of the World Health Organization histologic classification of thymic epithelial tumors and its prognosis: a clinicopathologic study of 108 patients from China. Honglin Yin ; Jun Du ; Zhenfeng Lu ; Xia Jiao ; Jiandong Wang ; Xiaojun Zhou Int J Surg Pathol; 2009 Jun; 17(3):255-61. PubMed ID: 19443889 [TBL] [Abstract][Full Text] [Related]
24. [Prognosis of surgically treated thymic epithelial tumors]. Horinouchi H; Asakura K; Kimura Y; Takeuchi K; Kawamura M; Watanabe M; Eguchi K; Kobayashi K Nihon Geka Gakkai Zasshi; 2006 Nov; 107(6):262-7. PubMed ID: 17147284 [TBL] [Abstract][Full Text] [Related]
25. New WHO histologic classification predicts prognosis of thymic epithelial tumors: a clinicopathologic study of 200 thymoma cases from China. Chen G; Marx A; Chen WH; Yong J; Puppe B; Stroebel P; Mueller-Hermelink HK Cancer; 2002 Jul; 95(2):420-9. PubMed ID: 12124843 [TBL] [Abstract][Full Text] [Related]
26. Desmoglein 3 and p40 immunoreactivity in neoplastic and nonneoplastic thymus: a potential adjunct to help resolve selected diagnostic and staging problems. Walts AE; Hiroshima K; Marchevsky AM Ann Diagn Pathol; 2015 Aug; 19(4):216-20. PubMed ID: 25979154 [TBL] [Abstract][Full Text] [Related]
27. Apoptosis, bcl-2 protein, and Fas antigen in thymic epithelial tumors. Tateyama H; Eimoto T; Tada T; Inagaki H; Hattori H; Takino H Mod Pathol; 1997 Oct; 10(10):983-91. PubMed ID: 9346177 [TBL] [Abstract][Full Text] [Related]
28. Corpuscular thymoma: entity or variant of organotypical thymomas WHO B2/B3? Laeng RH; Eimoto T; Kuo TT; Zettl A; Marx A; Moschopulos M; Tateyama H; Shimokawa K Pathol Res Pract; 2006; 202(10):697-704. PubMed ID: 16887284 [TBL] [Abstract][Full Text] [Related]
29. Immunohistochemical staining for bcl-2 and mcl-1 in intrathyroidal epithelial thymoma (ITET)/carcinoma showing thymus-like differentiation (CASTLE) and cervical thymic carcinoma. Dorfman DM; Shahsafaei A; Miyauchi A Mod Pathol; 1998 Oct; 11(10):989-94. PubMed ID: 9796728 [TBL] [Abstract][Full Text] [Related]
30. Absence of gene mutations in KIT-positive thymic epithelial tumors. Tsuchida M; Umezu H; Hashimoto T; Shinohara H; Koike T; Hosaka Y; Eimoto T; Hayashi JI Lung Cancer; 2008 Dec; 62(3):321-5. PubMed ID: 18486988 [TBL] [Abstract][Full Text] [Related]
31. Activation ratio of MMP-2 and expression of MT1-MMP are correlated in thymic epithelial tumours. Wang Y; Xu HT; Ueda Y; Shimasaki M; Wang EH Pathology; 2007 Oct; 39(5):486-90. PubMed ID: 17886098 [TBL] [Abstract][Full Text] [Related]
32. Immunohistochemical status of PD-L1 in thymoma and thymic carcinoma. Katsuya Y; Fujita Y; Horinouchi H; Ohe Y; Watanabe S; Tsuta K Lung Cancer; 2015 May; 88(2):154-9. PubMed ID: 25799277 [TBL] [Abstract][Full Text] [Related]
33. Sex steroid receptors in rheumatoid arthritis. Ishizuka M; Hatori M; Suzuki T; Miki Y; Darnel AD; Tazawa C; Sawai T; Uzuki M; Tanaka Y; Kokubun S; Sasano H Clin Sci (Lond); 2004 Mar; 106(3):293-300. PubMed ID: 14570589 [TBL] [Abstract][Full Text] [Related]
34. Long-term survival and prognostic factors in thymic epithelial tumours. Rea F; Marulli G; Girardi R; Bortolotti L; Favaretto A; Galligioni A; Sartori F Eur J Cardiothorac Surg; 2004 Aug; 26(2):412-8. PubMed ID: 15296907 [TBL] [Abstract][Full Text] [Related]
35. Mutational status of the epidermal growth factor receptor (EGFR) gene in thymomas and thymic carcinomas. Meister M; Schirmacher P; Dienemann H; Mechtersheimer G; Schnabel PA; Kern MA; Herpel E; Xu EC; Muley T; Thomas M; Rieker RJ Cancer Lett; 2007 Apr; 248(2):186-91. PubMed ID: 16919868 [TBL] [Abstract][Full Text] [Related]
36. World Health Organization histologic classification: an independent prognostic factor in resected thymomas. Rena O; Papalia E; Maggi G; Oliaro A; Ruffini E; Filosso P; Mancuso M; Novero D; Casadio C Lung Cancer; 2005 Oct; 50(1):59-66. PubMed ID: 16009453 [TBL] [Abstract][Full Text] [Related]
37. Preoperative steroid pulse therapy for invasive thymoma: clinical experience and mechanism of action. Kobayashi Y; Fujii Y; Yano M; Sasaki H; Yukiue H; Haneda H; Suzuki E; Endo K; Kawano O Cancer; 2006 May; 106(9):1901-7. PubMed ID: 16598701 [TBL] [Abstract][Full Text] [Related]
38. Aberrant methylation: common in thymic carcinomas, rare in thymomas. Suzuki M; Chen H; Shigematsu H; Ando S; Iida T; Nakajima T; Fujisawa T; Kimura H Oncol Rep; 2005 Dec; 14(6):1621-4. PubMed ID: 16273266 [TBL] [Abstract][Full Text] [Related]
39. Epidermal growth factor receptor expression in invasive thymoma. Henley JD; Koukoulis GK; Loehrer PJ J Cancer Res Clin Oncol; 2002 Mar; 128(3):167-70. PubMed ID: 11935304 [TBL] [Abstract][Full Text] [Related]
40. Prognosis of thymic epithelial tumors according to the new World Health Organization histologic classification. Park MS; Chung KY; Kim KD; Yang WI; Chung JH; Kim YS; Chang J; Kim JH; Kim SK; Kim SK Ann Thorac Surg; 2004 Sep; 78(3):992-7; discussion 997-8. PubMed ID: 15337034 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]